Pharma News

5 August 2025

LENZ Therapeutics announces USFDA approval of VIZZ for the Treatment of Presbyopia

LENZ Therapeutics, Inc announced the US Food and Drug Administration approved VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults. Samples are anticipated in the United States as early as October 2025, with commercial product to be broadly available by mid-Q4 2025. Direct-to-eye care professional sales and marketing activities to be initiated immediately.

5 August 2025

AbbVie's RINVOQ® Shows Promising Results in Phase 3 Trial for Severe Alopecia Areata

AbbVie announced positive topline results from the first of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib (RINVOQ®; 15 mg and 30 mg, once daily) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline SALT score of 83.8 (approximately 16% scalp hair coverage).

1 August 2025

Trump Sends Ultimatum to Big Pharma : Slash Drug Prices or Face Action

US President Donald J. Trump has issued a sweeping ultimatum to 17 of the worlds largest pharmaceutical companies, demanding they drastically lower drug prices for Americans within 60 days or face aggressive regulatory and trade action.

1 August 2025

Government intensifies promotion and regulation of AYUSH systems of medicine across India

The Ministry of Ayush is actively promoting and strengthening the AYUSH systems of medicine Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homoeopathy through a comprehensive strategy supported by both centrally sponsored and central sector schemes.

1 August 2025

A new approach to treatment of liver cirrhosis

A team of Indian scientists may have found a way to improve the drainage capacity of lymphatic vessels in the liver and intestine that fails in case of cirrhosis, by using nanocarriers filled with a powerful protein called VEGF-C.

30 July 2025

FDA Approves Medication to Treat 2 Rare Diseases that Can Lead to Kidney Failure

The U.S. Food and Drug Administration (FDA) approved a new indication for Empaveli (pegcetacoplan) injection to treat adults and children aged 12 years and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), two rare kidney diseases that can cause kidney failure. This will be the first medication approved for children with C3G and the first medication approved for the treatment of adults and children with primary IC-MPGN.

25 July 2025

New Hope for HIV Cure: Scientists Discover Special Killer T Cells That Hunt Hidden Viruses

New research has taken us a step closer to finding a cure for human immunodeficiency virus, as well as other infections including the glandular fever virus, which is associated with the development of lymphoma.

25 July 2025

Swiss Genome of the 1918 Influenza Virus Reconstructed

Researchers from the universities of Basel and Zurich have used a historical specimen from UZHs Medical Collection to decode the genome of the virus responsible for the 1918–1920 influenza pandemic in Switzerland.

25 July 2025

IIHMR University's Annual Convocation 2025 Felicitates 423 Graduates, Highlights Global Recognition and Academic Excellence

IIHMR University, Jaipur, organised its annual convocation ceremony on Saturday, July 19, 2025, at the university campus. Chief Guest Hon'ble Governor of Rajasthan, Shri HaribhauKishanraoBagde, shared, "I’m happy to observe that all four students who received gold medals at IIHMR University were females. He requested all the graduating students to apply the knowledge and skills acquired over the past two years towards the noble cause of nation-building.

24 July 2025

NATCO Pharma’s Mekaguda API unit receives EIR from U.S. FDA following June inspection

NATCO Pharmas Active Pharmaceutical Ingredient (API) facility located in Mekaguda, near Hyderabad, has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration

Search

LENZ Therapeutics announces USFDA approval of VIZZ for the Treatment of Presbyopia

RECOMMENDED POSTS

Subscribe with us

Jobs by Category